Involvement of nuclear receptors in the enhanced IL-2 production by melatonin in Jurkat cells.
This report shows that melatonin enhances IL-2 production by Jurkat cells via a nuclear receptor-mediated mechanism. Jurkat cells express nuclear (RZR alpha, ROR alpha 1, and ROR alpha 2) and membrane (mt1) melatonin receptors, and melatonin binds to Jurkat nuclei and membranes with the same affinity described for human peripheral blood mononuclear cells (PBMCs). Melatonin enhances IL-2 production by Jurkat cells activated by either phytohemagglutinin (PHA) or phorbol myristate acetate (PMA). PHA activation of Jurkat cells does not change the profile of melatonin receptor expression; on the contrary, PMA activation negatively regulates the mt1 receptor. In the absence of the membrane receptor, melatonin still activates the IL-2 production. These results show that the expression of the nuclear melatonin receptor is sufficient for melatonin to activate IL-2 production by Jurkat cells.
Department of Medical Biochemistry and Molecular Biology, University of Seville School of Medicine, Virgen Macarena Hospital, Seville, Spain. guerrero@cica.es
J M
JM
Guerrero
D
D
Pozo
S
S
García-Mauriño
C
C
Osuna
P
P
Molinero
J R
JR
Calvo
D006801:Humans; D007376:Interleukin-2 / Q000276:immunology*; D019169:Jurkat Cells; D008550:Melatonin / Q000276:immunology* / Q000494:pharmacology; D018160:Receptors, Cytoplasmic and Nuclear / Q000276:immunology; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D007376:Interleukin-2; D018160:Receptors, Cytoplasmic and Nuclear; D008550:Melatonin